{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:07:40Z","timestamp":1782281260514,"version":"3.54.5"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022661","name":"European Brain Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Health Serv."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Progressive ataxias are a diverse and rare group of neurodegenerative conditions characterised by unsteadiness, incoordination and slurred speech. Additional neurological features and pathology outside the central nervous system may also be present.\n                      <jats:sup>1<\/jats:sup>\n                      Optimal management of these complex conditions requires access to specialist diagnostics and treatment via Specialist Ataxia Centres (SACs). Greater understanding of factors impacting on SAC access may help to maximise utilisation.\n                      <jats:sup>2<\/jats:sup>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This study explored factors associated with referral to SACs or discontinued access.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Responses to cross-sectional surveys conducted separately in three European countries were collated. The national surveys were conducted at different times and the question format evolved, requiring responses to be harmonised. The 550 individual responses were examined for associations between SAC access and respondent characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Respondents with a genetic diagnosis were observed to have greater representation in SACs in Italy and Germany than in the UK, with this contrast being most prominent with a diagnosis of Friedreich's ataxia. Respondents with Idiopathic Cerebellar Ataxia also had significantly lower proportion of referrals in the UK relative to Germany and Italy. Fewer reported comorbidities, being in employment, and shorter travel time to SACs were associated with reported SAC attendance or referral. Increasing mobility impairment was associated with reported discontinuation of SAC attendance. No statistically significant associations were observed between SAC attendance and referral source, time since diagnosis, or reported impact of ataxia on daily living.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Statistically significant differences between SAC and non-SAC respondent cohorts were observed, as well as variations in SAC access between countries. These findings highlight factors that may be relevant to SAC utilisation. The results suggest potential areas for further investigation, including strategies to support access, such as telehealth, and may inform the design of future multinational studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/frhs.2026.1787866","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:45:18Z","timestamp":1782279918000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Access to specialist ataxia centres in Europe: cross-sectional surveys in the United Kingdom, Italy, and Germany"],"prefix":"10.3389","volume":"6","author":[{"given":"Suzanne","family":"Booth","sequence":"first","affiliation":[{"name":"Ataxia Centre, Queen Square Institute of Neurology, Department of Molecular and Movement Neurosciences, University College London","place":["United Kingdom"]},{"name":"City St George\u2019s, University of London","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Vallortigara","sequence":"additional","affiliation":[{"name":"Ataxia Centre, Queen Square Institute of Neurology, Department of Molecular and Movement Neurosciences, University College London","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hurt","sequence":"additional","affiliation":[{"name":"City St George\u2019s, University of London","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Greenfield","sequence":"additional","affiliation":[{"name":"Ataxia UK","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Hunt","sequence":"additional","affiliation":[{"name":"Ataxia UK","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Giunti","sequence":"additional","affiliation":[{"name":"Ataxia Centre, Queen Square Institute of Neurology, Department of Molecular and Movement Neurosciences, University College London","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13023-019-1013-9","article-title":"Guidelines on the diagnosis and management of the progressive ataxias","volume":"14","author":"De Silva","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/jnc.12317","article-title":"Clinical features of friedreich\u2019s ataxia: classical and atypical phenotypes","volume":"126","author":"Parkinson","year":"2013","journal-title":"J Neurochem"},{"key":"B3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1474-4422(18)30042-5","article-title":"Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study","volume":"17","author":"Diallo","year":"2018","journal-title":"Lancet Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","article-title":"Spinocerebellar ataxia","volume":"5","author":"Klockgether","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/B978-0-444-64189-2.00005-6","article-title":"Recessive ataxias","volume":"155","author":"Synofzik","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12311-017-0885-2","article-title":"Epidemiology of cerebellar diseases and therapeutic approaches","volume":"17","author":"Salman","year":"2018","journal-title":"Cerebellum"},{"key":"B7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00415-009-0015-2","article-title":"The genetic aetiology of late-onset chronic progressive cerebellar ataxia. A population-based study","volume":"256","author":"Wardle","year":"2009","journal-title":"J Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11910-012-0267-6","article-title":"Recent advances in the genetics of cerebellar ataxias","volume":"12","author":"Sailer","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1136\/jnnp.2003.014662","article-title":"Population based study of late onset cerebellar ataxia in south east Wales","volume":"75","author":"Muzaimi","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1212\/WNL.0000000000005055","article-title":"Comprehensive systematic review summary: treatment of cerebellar motor dysfunction and ataxia: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology","volume":"90","author":"Zesiewicz","year":"2018","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/practneurol-2018-002096","article-title":"Diagnosis and management of progressive ataxia in adults","volume":"19","author":"De Silva","year":"2019","journal-title":"Pract Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2147\/JMDH.S292945","article-title":"Friedreich ataxia: multidisciplinary clinical care","volume":"14","author":"Lynch","year":"2021","journal-title":"J Multidiscip Healthc"},{"key":"B13","article-title":"About rare diseases","year":""},{"key":"B14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13023-017-0618-0","article-title":"Review of 11 national policies for rare diseases in the context of key patient needs","volume":"12","author":"Dharssi","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3325\/cmj.2019.60.156","article-title":"Toward earlier diagnosis and treatment of rare neurological disorders: the value of coordinated care and specialist centers","volume":"60","author":"Giunti","year":"2019","journal-title":"Croat Med J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s13023-023-02907-y","article-title":"Patient pathways for rare diseases in Europe: ataxia as an example","volume":"18","author":"Vallortigara","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/1352458508097919","article-title":"Earlier disability of the patients followed in multiple sclerosis centers compared to outpatients","volume":"15","author":"Debouverie","year":"2009","journal-title":"Mult Scler"},{"key":"B18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.7224\/1537-2073.2016-039","article-title":"Preferences for multiple sclerosis treatments: using a discrete-choice experiment to examine differences across subgroups of US patients","volume":"19","author":"Mansfield","year":"2017","journal-title":"Int J MS Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s40120-022-00366-4","article-title":"Therapeutic decision-making under uncertainty in the management of spinal muscular atrophy: results from DECISIONS-SMA study","volume":"11","author":"Saposnik","year":"2022","journal-title":"Neurol Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.7224\/1537-2073.2016-016","article-title":"Barriers to the accessibility and continuity of health-care services in people with multiple sclerosis: a literature review","volume":"19","author":"Chiu","year":"2017","journal-title":"Int J MS Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1212\/01.wnl.0000306411.46934.ef","article-title":"Access to and utilization of neurologists by people with multiple sclerosis","volume":"70","author":"Minden","year":"2008","journal-title":"Neurology"},{"key":"B22","volume-title":"The Value of Treatment Policy White Paper: Towards optimizing research and care for brain disorders","year":"2017"},{"key":"B23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s13023-023-02971-4","article-title":"Impact of specialist ataxia centres on health service resource utilisation and costs across Europe: cross-sectional survey","volume":"18","author":"Morris","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mds.28313","article-title":"Assessment of ataxia rating scales and cerebellar functional tests: critique and recommendations","volume":"36","author":"Perez-Lloret","year":"2021","journal-title":"Mov Disord"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.apmr.2017.02.027","article-title":"Rehabilitation services use and patient-reported outcomes among older adults in the United States","volume":"98","author":"Gell","year":"2017","journal-title":"Arch Phys Med Rehabil"},{"key":"B26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.apmr.2007.08.122","article-title":"Determinants of utilization of physical rehabilitation services for persons with chronic and disabling conditions: an exploratory study","volume":"89","author":"Elrod","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"key":"B27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/ana.23698","article-title":"Central role and mechanisms of \u03b2-cell dysfunction and death in friedreich ataxia-associated diabetes","volume":"72","author":"Cnop","year":"2012","journal-title":"Ann Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"104655","DOI":"10.1016\/j.msard.2023.104655","article-title":"Inequality in accessing healthcare for people with MS","volume":"72","author":"Lechner-Scott","year":"2023","journal-title":"Mult Scleral Relat Disord"},{"key":"B29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1212\/CPJ.0000000000001167","article-title":"Disparities in telehealth care in multiple sclerosis","volume":"12","author":"Marrie","year":"2022","journal-title":"Neurol Clin Pract"},{"key":"B30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/DNND.S131729","article-title":"Employment of patients with multiple sclerosis: the influence of psychosocial-structural coping and context","volume":"8","author":"Vijayasingham","year":"2018","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1177\/1352458513482372","article-title":"State vocational rehabilitation services and employment in multiple sclerosis","volume":"19","author":"Chiu","year":"2013","journal-title":"Mult Scler"},{"key":"B32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.msard.2018.11.033","article-title":"Patterns of care for multiple sclerosis in a setting of universal care access: a cross-sectional study","volume":"28","author":"Barin","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jnc.12215","article-title":"Prevalence gradients of friedreich\u2019s ataxia and R1b haplotype in Europe co-localize, suggesting a common palaeolithic origin in the franco-Cantabrian ice age refuge","volume":"126","author":"Vankan","year":"2013","journal-title":"J Neurochem"},{"key":"B34","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/PEP.0b013e3181faeb11","article-title":"Sharing of lessons learned from multisite research","volume":"22","author":"Fiss","year":"2010","journal-title":"Pediatr Phys Ther"}],"container-title":["Frontiers in Health Services"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frhs.2026.1787866\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:45:21Z","timestamp":1782279921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frhs.2026.1787866\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":34,"alternative-id":["10.3389\/frhs.2026.1787866"],"URL":"https:\/\/doi.org\/10.3389\/frhs.2026.1787866","relation":{},"ISSN":["2813-0146"],"issn-type":[{"value":"2813-0146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"article-number":"1787866"}}